City
Epaper

US won't release AstraZeneca's COVID vaccine for export until sure about safety, says official

By ANI | Updated: April 30, 2021 12:20 IST

The US Food and Drug Administration will not release AstraZeneca's coronavirus vaccine for export to other countries until it is sure the doses have been manufactured to US quality standards and will be safe and effective, a government official told CNN on Thursday.

Open in App

The US Food and Drug Administration will not release AstraZeneca's coronavirus vaccine for export to other countries until it is sure the doses have been manufactured to US quality standards and will be safe and effective, a government official told CNN on Thursday.

According to CNN, The White House said on Monday it would ship doses of AstraZeneca vaccine to other countries, including India, after a safety review by the FDA.

AstraZeneca has yet to apply for emergency use authorisation (EUA) in the US, but the company has been making tens of millions of doses in the US in the expectation that it will apply for and receive EUA eventually.

Many other countries have been clamouring for vaccine and international groups have criticized the US for buying up vaccine doses while billions of people around the world go without.

The safety review will be thorough, a government official with knowledge of the process who was not authorized to speak on the subject and requested anonymity told CNN.

While a EUA is not needed to export vaccines, the official said, the US would not export any vaccine that did not meet US safety, efficacy and manufacturing quality standards.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Us Food And Drug AdministrationAstrazenecaAstrazeneca plc.Astrazeneca plc
Open in App

Related Stories

HealthDCGI Orders Withdrawal of AstraZeneca’s Anti-Cancer Drug Olaparib for Certain Treatments

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’

NationalCovishield Vaccine Side Effect: Serum Institute Faces Legal Action As Parents of Deceased Girls Prepare Lawsuit

International Realted Stories

InternationalTaiwan detects 7 sorties of Chinese aircraft near its territory

InternationalTaiwan: MAC flags essay contest tied to CCP-affiliated publisher for possible legal breach

InternationalArab Parliament, AL condemn Israeli airstrikes near Syria's Presidential Palace

InternationalSecond Emirati-Iraqi Business Forum discusses enhancing trade partnerships

InternationalEuropean Commission welcomes Ukraine-US fossil fuel deal that doesn't hinder EU accession